Michael Gelband’s Nutex Health NUTX Stock Holding History

Michael Gelband’s Portfolio NUTX Stock Details NUTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-682	Closed	-$43K	–	2000
2023 Q2	$43K	Buy	+682	New	+$58.5K	﹤0.01%	1780

Other funds holding NUTX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

MCM

MAI Capital Management Independence, Ohio $26.6B AUM 22.97% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

SWM

Scissortail Wealth Management Tulsa, Oklahoma $520M AUM 21.73% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Swiss National Bank Zurich, Switzerland $191B AUM 45.21% 1-Year Est. Return

Creative Planning Overland Park, Kansas $171B AUM 24.68% 1-Year Est. Return

Michael Gelband's NUTX Position: Q3 2023 in Review

Michael Gelband sold out of Nutex Health (NUTX) in Q3 2023, closing a stake of 682 shares — an estimated $43K sold.

Michael Gelband first reported a position in NUTX in Q2 2023 and held it in 1 quarter. The position peaked at $43K in Q2 2023. 59 funds tracked by Wall St. Rank hold NUTX as of Q3 2023.

Michael Gelband reported no remaining Nutex Health position as of Q3 2023 after selling out during the quarter.
Michael Gelband sold 682 Nutex Health shares in Q3 2023, an estimated $43K.
Michael Gelband first reported a position in Nutex Health in Q2 2023 and held it in 1 quarter.
Michael Gelband's Nutex Health position peaked at $43K in Q2 2023.
59 funds tracked by Wall St. Rank held Nutex Health as of Q3 2023.

Based on ExodusPoint Capital Management's 13F filing for Q3 2023, filed 13 Nov 2023.